CHALLENGING BEHAVIOURAL AND AUTISTIC TRAITS WITH EPILEPSY IN 2 MALAYSIAN SIBLINGS WITH A NOVEL PIGA

来源 :The 2nd International Rare Diseases Research Consortium Conf | 被引量 : 0次 | 上传用户:snoopy_cp
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
The Phosphatidylinositol Glycan Class A (PIGA) protein is essential for the first step of Glycosylphosphatidylinositol (GPI) anchor biosynthesis.GPl anchors are important for normal development,particularly of the CNS.Germline mutations in PIGA at Xp22.2 are now recognized to cause Multiple congenital anomalies-hypotonia-seizures syndrome-2 (MCAHS2).
其他文献
Maternal Immune Activation (MIA) has been highlighted to be a risk factor for neurodevelopmental disorders such as schizophrenia and autism.However,the link between MIA and epigenomic modifications ha
会议
Hirschsprung disease (HSCR) is a congenital birth defect with relatively low prevalence (1 per 5000 live births) in world-wide population.Previous genetic and functional studies reveal HSCR is caused
会议
The International Rare Diseases Research Consortium (IRDiRC) brings together members that share goals and principles,and have agreed to work in a coordinated and collaborative manner within a multinat
会议
The rapid uptake of exome sequencing has greatly increased the molecular diagnosis in Mendelian genetic syndromes.Providing adequate genetic evidence for rare syndromes remains challenging,with genes
会议
Ubiad1 is a rare disease SCCD gene which has been extensively studied.However,the exact function of ubiad1 in the apoptosis remains unclear.The aim of this research was to study the apoptotic effect o
会议
Annotation of genes responsible for human diseases remains a big challenge in the post-genome era.Making use of genomic features such as sequences conservation or physicochemical properties of amino a
会议
With the rapid advances in high-throughput sequencing technologies,exome sequencing and targeted region sequencing will become routine approaches for identifying mutations of inherited diseases in bot
In this article,we would introduce our unique style of NANBYO (rare and intractable) diseases patient registry led by patient organizations and themselves,named"J-RARE.net".J-RARE.net is mixed service
会议
In this article,we would introduce our Drug Development Support Program (DDSP) about mitochondrial diseases.KOINOBORI is a nonprofit organization to bring accumulated knowledge and experience together
会议
Building on its unique genetic diversity and a strong tradition of collaborative research,Canada has joined the global effort to tackle rare diseases.The Canadian Institutes of Health Research,in clos
会议